Beranda › Hidradenitis Suppurativa › New York
Uji klinis Hidradenitis Suppurativa di New York
7 studi untuk Hidradenitis Suppurativa mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Cameron Dermatology, New York
- Icahn School Of Med At Mount Sinai, New York
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07665437A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Equity Medical (LLC)- Site Number : 8400010, The Bronx
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 5, New York
- Clinical Site 4, The Bronx
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07828860Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Dr Bobby Buka, Md Greenwich Village, New York
- Equity Medical, Llc, New York
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07049575Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US082, East Syracuse
- Investigative Site US034, New York
- Investigative Site US081, New York
- dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06855498A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Equity Medical, LLC, The Bronx
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07384975A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Northwell Health Physician Partners, Lake Success
- Mount Sinai Doctors, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT07244263Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.